These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 31123085)
1. The E3 ligase VHL promotes follicular helper T cell differentiation via glycolytic-epigenetic control. Zhu Y; Zhao Y; Zou L; Zhang D; Aki D; Liu YC J Exp Med; 2019 Jul; 216(7):1664-1681. PubMed ID: 31123085 [TBL] [Abstract][Full Text] [Related]
2. E3 Ligase VHL Promotes Group 2 Innate Lymphoid Cell Maturation and Function via Glycolysis Inhibition and Induction of Interleukin-33 Receptor. Li Q; Li D; Zhang X; Wan Q; Zhang W; Zheng M; Zou L; Elly C; Lee JH; Liu YC Immunity; 2018 Feb; 48(2):258-270.e5. PubMed ID: 29452935 [TBL] [Abstract][Full Text] [Related]
3. E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity. Lee JH; Elly C; Park Y; Liu YC Immunity; 2015 Jun; 42(6):1062-74. PubMed ID: 26084024 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factors in CD4 Cho SH; Raybuck AL; Blagih J; Kemboi E; Haase VH; Jones RG; Boothby MR Proc Natl Acad Sci U S A; 2019 Apr; 116(18):8975-8984. PubMed ID: 30988188 [TBL] [Abstract][Full Text] [Related]
6. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases. Paltoglou S; Roberts BJ Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177 [TBL] [Abstract][Full Text] [Related]
7. HIF1α-Dependent Metabolic Signals Control the Differentiation of Follicular Helper T Cells. Dong L; He Y; Zhou S; Cao Y; Li Y; Bi Y; Liu G Cells; 2019 Nov; 8(11):. PubMed ID: 31744227 [TBL] [Abstract][Full Text] [Related]
8. Homotypic association between tumour-associated VHL proteins leads to the restoration of HIF pathway. Chung J; Roberts AM; Chow J; Coady-Osberg N; Ohh M Oncogene; 2006 May; 25(21):3079-83. PubMed ID: 16407835 [TBL] [Abstract][Full Text] [Related]
9. The ubiquitin ligase Peli1 inhibits ICOS and thereby Tfh-mediated immunity. Huang X; Hao S; Liu J; Huang Y; Liu M; Xiao C; Wang Y; Pei S; Yu T; Xu J; Wang H; Dai D; Su X; Xiao Y Cell Mol Immunol; 2021 Apr; 18(4):969-978. PubMed ID: 33707688 [TBL] [Abstract][Full Text] [Related]
10. In vivo CRISPR screens reveal a HIF-1α-mTOR-network regulates T follicular helper versus Th1 cells. Huang B; Phelan JD; Preite S; Gomez-Rodriguez J; Johansen KH; Shibata H; Shaffer AL; Xu Q; Jeffrey B; Kirby M; Anderson S; Yang Y; Gossa S; McGavern DB; Staudt LM; Schwartzberg PL Nat Commun; 2022 Feb; 13(1):805. PubMed ID: 35145086 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720 [TBL] [Abstract][Full Text] [Related]
12. Melatonin and the von Hippel-Lindau/HIF-1 oxygen sensing mechanism: A review. Vriend J; Reiter RJ Biochim Biophys Acta; 2016 Apr; 1865(2):176-83. PubMed ID: 26899267 [TBL] [Abstract][Full Text] [Related]
13. Immune regulation by protein ubiquitination: roles of the E3 ligases VHL and Itch. Aki D; Li Q; Li H; Liu YC; Lee JH Protein Cell; 2019 Jun; 10(6):395-404. PubMed ID: 30413999 [TBL] [Abstract][Full Text] [Related]
14. Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: role of HIF in antiviral response. Hwang II; Watson IR; Der SD; Ohh M J Virol; 2006 Nov; 80(21):10712-23. PubMed ID: 16928739 [TBL] [Abstract][Full Text] [Related]
15. Role of the C-terminal alpha-helical domain of the von Hippel-Lindau protein in its E3 ubiquitin ligase activity. Lewis MD; Roberts BJ Oncogene; 2004 Mar; 23(13):2315-23. PubMed ID: 14691445 [TBL] [Abstract][Full Text] [Related]
16. Von Hippel-Lindau Acts as a Metabolic Switch Controlling Nephron Progenitor Differentiation. Cargill K; Hemker SL; Clugston A; Murali A; Mukherjee E; Liu J; Bushnell D; Bodnar AJ; Saifudeen Z; Ho J; Bates CM; Kostka D; Goetzman ES; Sims-Lucas S J Am Soc Nephrol; 2019 Jul; 30(7):1192-1205. PubMed ID: 31142573 [TBL] [Abstract][Full Text] [Related]
17. Expression of HIF-1 and ubiquitin in conventional renal cell carcinoma: relationship to mutations of the von Hippel-Lindau tumor suppressor gene. Hughson MD; He Z; Liu S; Coleman J; Shingleton WB Cancer Genet Cytogenet; 2003 Jun; 143(2):145-53. PubMed ID: 12781449 [TBL] [Abstract][Full Text] [Related]
18. Fibrosis and hypoxia-inducible factor-1α-dependent tumors of the soft tissue on loss of von Hippel-Lindau in mesenchymal progenitors. Mangiavini L; Merceron C; Araldi E; Khatri R; Gerard-O'Riley R; Wilson TL; Sandusky G; Abadie J; Lyons KM; Giaccia AJ; Schipani E Am J Pathol; 2015 Nov; 185(11):3090-101. PubMed ID: 26348575 [TBL] [Abstract][Full Text] [Related]
19. USP9X destabilizes pVHL and promotes cell proliferation. Zhang C; Peng Z; Zhu M; Wang P; Du X; Li X; Liu Y; Jin Y; McNutt MA; Yin Y Oncotarget; 2016 Sep; 7(37):60519-60534. PubMed ID: 27517496 [TBL] [Abstract][Full Text] [Related]
20. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Carroll VA; Ashcroft M Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]